Karo Pharma AB buy Morgan Stanley
Start price
24.01.24
/
50%
€5.44
Target price
24.01.25
€28.46
Performance (%)
-
End price
25.01.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Karo Pharma AB | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its price target lowered by analysts at Morgan Stanley from $34.00 to $31.00. They now have an "overweight" rating on the stock.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten